Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
J Virol Methods
2022 Feb 01;300:114382. doi: 10.1016/j.jviromet.2021.114382.
Show Gene links
Show Anatomy links
Alternative SARS-CoV-2 detection protocol from self-collected saliva for mass diagnosis and epidemiological studies in low-incoming regions.
de Oliveira LPR
,
Cabral AD
,
Dos Santos Carmo AM
,
Duran AF
,
Fermino DM
,
Veiga GRL
,
da Costa Aguiar Alves B
,
Santana CM
,
Garcia FB
,
Santos ES
,
Jordão FT
,
Siqueira AM
,
de Campos IB
,
Colpas DR
,
Almeida FN
,
Fonseca FLA
,
Sperança MA
.
???displayArticle.abstract???
Until mass vaccination befalls, control of the new betacoronavirus-associated severe acute respiratory syndrome pandemic (SARS-CoV-2) is based on decreasing virus circulation by social distancing and blocking transmission foci after diagnosis. Globally adopted SARS-CoV-2 diagnostic criteria embrace viral RNA detection by quantitative reverse-transcription polymerase chain reaction (qRT-PCR) on nasopharynx secretions, which requires healthcare facilities and specialized personnel for sample collection. To develop an alternative protocol, hydrophilic cotton as the material and saliva as the source for biological sample collection in qRT-PCR/RT-endpoint-PCR SARS-CoV-2 diagnostic methods prepared with local consumables were evaluated using 99 archived nasopharynx samples previously diagnosed as positive for SARS-CoV-2 and 111 prospective saliva samples pared with nasopharynx samples from patients attending the local reference ABC Medical School diagnostic laboratory. The kappa agreement coefficient between the SARS-CoV-2 qRT-PCR and RT-endpoint-PCR was k = 0.97 (95 % CI 0.92-1.00) and k = 0.90 (95 % CI 0.81-0.99), respectively, on SARS-CoV-2-positive archived samples, with the initial qRT-PCR CT under 25. The agreement coefficient of the SARS-CoV-2 alternative saliva diagnostic protocol, when used to test the paired nasopharynx samples, was k = 0.79 (95 % CI 0.56-1,00). These data support that the SARS-CoV-2 diagnostic assay based on self-collected saliva on cotton represents an alternative protocol for mass diagnosis and epidemiological studies in low-income regions.
Archer,
Differentiating COVID-19 Pneumonia From Acute Respiratory Distress Syndrome and High Altitude Pulmonary Edema: Therapeutic Implications.
2020, Pubmed
Archer,
Differentiating COVID-19 Pneumonia From Acute Respiratory Distress Syndrome and High Altitude Pulmonary Edema: Therapeutic Implications.
2020,
Pubmed
Azzi,
Saliva is a reliable tool to detect SARS-CoV-2.
2020,
Pubmed
Chate,
Presentation of pulmonary infection on CT in COVID-19: initial experience in Brazil.
2020,
Pubmed
Chen,
Emerging coronaviruses: Genome structure, replication, and pathogenesis.
2020,
Pubmed
Fried,
The Variety of Cardiovascular Presentations of COVID-19.
2020,
Pubmed
Hallal,
Trends in the prevalence of COVID-19 infection in Rio Grande do Sul, Brazil: repeated serological surveys.
2020,
Pubmed
Huang,
Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19.
2020,
Pubmed
Jin,
Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms.
2020,
Pubmed
Li,
Molecular diagnosis of COVID-19: Current situation and trend in China (Review).
2020,
Pubmed
Linares,
Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms.
2020,
Pubmed
Lovato,
Clinical Presentation of COVID-19: A Systematic Review Focusing on Upper Airway Symptoms.
2020,
Pubmed
Lu,
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.
2020,
Pubmed
Matsuda,
Field evaluation of COVID-19 antigen tests versus RNA based detection: Potential lower sensitivity compensated by immediate results, technical simplicity, and low cost.
2021,
Pubmed
McHugh,
Interrater reliability: the kappa statistic.
2012,
Pubmed
Oran,
Prevalence of Asymptomatic SARS-CoV-2 Infection : A Narrative Review.
2020,
Pubmed
Ott,
Stability of SARS-CoV-2 RNA in Nonsupplemented Saliva.
2021,
Pubmed
Pasomsub,
Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study.
2021,
Pubmed
Patel,
Transmission routes of SARS-CoV-2.
2020,
Pubmed
Qi,
Multicenter analysis of clinical characteristics and outcomes in patients with COVID-19 who develop liver injury.
2020,
Pubmed
Rodríguez-Ezpeleta,
Construction of cDNA libraries: focus on protists and fungi.
2009,
Pubmed
Seah,
Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals.
2020,
Pubmed
Shirato,
Development of Genetic Diagnostic Methods for Detection for Novel Coronavirus 2019(nCoV-2019) in Japan.
2020,
Pubmed
Takeuchi,
Saliva-based PCR tests for SARS-CoV-2 detection.
2020,
Pubmed
Uchida,
Loop-Mediated Isothermal Amplification Screening for COVID-19 in Asymptomatic Preoperative Orthopedic Patients in a General Hospital in Kanagawa, Japan.
2020,
Pubmed
Wu,
Author Correction: A new coronavirus associated with human respiratory disease in China.
2020,
Pubmed
Wu,
A new coronavirus associated with human respiratory disease in China.
2020,
Pubmed
Wu,
SARS-CoV-2 is an appropriate name for the new coronavirus.
2020,
Pubmed
Wyllie,
Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2.
2020,
Pubmed
Xu,
Salivary Glands: Potential Reservoirs for COVID-19 Asymptomatic Infection.
2020,
Pubmed
Yang,
Patients with respiratory symptoms are at greater risk of COVID-19 transmission.
2020,
Pubmed
Zheng,
COVID-19 and the cardiovascular system.
2020,
Pubmed
